T. Rowe Price Associates’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.6M | Sell |
2,442,876
-583,825
| -19% | -$9.93M | ﹤0.01% | 773 |
|
|
2025
Q1 | $59.1M | Buy |
3,026,701
+1,273,559
| +73% | +$24.9M | 0.01% | 673 |
|
|
2024
Q4 | $43.5M | Buy |
1,753,142
+266,834
| +18% | +$6.62M | 0.01% | 796 |
|
|
2024
Q3 | $36.4M | Buy |
1,486,308
+92,635
| +7% | +$2.27M | ﹤0.01% | 840 |
|
|
2024
Q2 | $32.7M | Buy |
1,393,673
+147,484
| +12% | +$3.46M | ﹤0.01% | 838 |
|
|
2024
Q1 | $41.2M | Buy |
1,246,189
+1,207,699
| +3,138% | +$39.9M | 0.01% | 774 |
|
|
2023
Q4 | $1.05M | Buy |
38,490
+2,165
| +6% | +$58.9K | ﹤0.01% | 1850 |
|
|
2023
Q3 | $874K | Buy |
36,325
+2,100
| +6% | +$50.5K | ﹤0.01% | 1854 |
|
|
2023
Q2 | $1.09M | Buy |
34,225
+3,656
| +12% | +$117K | ﹤0.01% | 1755 |
|
|
2023
Q1 | $937K | Buy |
30,569
+971
| +3% | +$29.8K | ﹤0.01% | 1821 |
|
|
2022
Q4 | $1.16M | Buy |
29,598
+2,553
| +9% | +$99.9K | ﹤0.01% | 1693 |
|
|
2022
Q3 | $1.29M | Buy |
27,045
+3,560
| +15% | +$170K | ﹤0.01% | 1627 |
|
|
2022
Q2 | $909K | Buy |
23,485
+1,549
| +7% | +$60K | ﹤0.01% | 1941 |
|
|
2022
Q1 | $1.26M | Buy |
21,936
+3,136
| +17% | +$180K | ﹤0.01% | 1883 |
|
|
2021
Q4 | $1.5M | Sell |
18,800
-4,393
| -19% | -$350K | ﹤0.01% | 1823 |
|
|
2021
Q3 | $2.02M | Sell |
23,193
-2,691
| -10% | -$234K | ﹤0.01% | 1719 |
|
|
2021
Q2 | $3.33M | Sell |
25,884
-25,939
| -50% | -$3.34M | ﹤0.01% | 1588 |
|
|
2021
Q1 | $4.15M | Buy |
51,823
+41,630
| +408% | +$3.33M | ﹤0.01% | 1506 |
|
|
2020
Q4 | $832K | Buy |
+10,193
| New | +$832K | ﹤0.01% | 2013 |
|
|
2020
Q3 | – | Sell |
-444,449
| Closed | -$12.4M | – | 2586 |
|
|
2020
Q2 | $12.4M | Sell |
444,449
-11,998
| -3% | -$336K | ﹤0.01% | 1251 |
|
|
2020
Q1 | $8.22M | Buy |
+456,447
| New | +$8.22M | ﹤0.01% | 1262 |
|